IL145947A0 - Mutual prodrugs of amlodipine and atrovastatin - Google Patents

Mutual prodrugs of amlodipine and atrovastatin

Info

Publication number
IL145947A0
IL145947A0 IL14594700A IL14594700A IL145947A0 IL 145947 A0 IL145947 A0 IL 145947A0 IL 14594700 A IL14594700 A IL 14594700A IL 14594700 A IL14594700 A IL 14594700A IL 145947 A0 IL145947 A0 IL 145947A0
Authority
IL
Israel
Prior art keywords
atrovastatin
amlodipine
mutual prodrugs
prodrugs
mutual
Prior art date
Application number
IL14594700A
Other languages
English (en)
Original Assignee
Pfizer Prod Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Prod Inc filed Critical Pfizer Prod Inc
Publication of IL145947A0 publication Critical patent/IL145947A0/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/54—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound
    • A61K47/55—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound the modifying agent being also a pharmacologically or therapeutically active agent, i.e. the entire conjugate being a codrug
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Urology & Nephrology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyrrole Compounds (AREA)
IL14594700A 1999-05-27 2000-03-20 Mutual prodrugs of amlodipine and atrovastatin IL145947A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US13660899P 1999-05-27 1999-05-27
PCT/IB2000/000313 WO2000073298A1 (en) 1999-05-27 2000-03-20 Mutual prodrugs of amlodipine and atorvastatin

Publications (1)

Publication Number Publication Date
IL145947A0 true IL145947A0 (en) 2002-07-25

Family

ID=22473579

Family Applications (1)

Application Number Title Priority Date Filing Date
IL14594700A IL145947A0 (en) 1999-05-27 2000-03-20 Mutual prodrugs of amlodipine and atrovastatin

Country Status (41)

Country Link
US (1) US6486182B1 (de)
EP (1) EP1180102B9 (de)
JP (1) JP2003500487A (de)
KR (1) KR20020012247A (de)
CN (1) CN1352640A (de)
AP (1) AP2001002345A0 (de)
AR (1) AR022344A1 (de)
AT (1) ATE268764T1 (de)
AU (1) AU3313900A (de)
BG (1) BG106149A (de)
BR (1) BR0011006A (de)
CA (1) CA2375372C (de)
CO (1) CO5170457A1 (de)
CZ (1) CZ20014229A3 (de)
DE (1) DE60011424T2 (de)
DK (1) DK1180102T3 (de)
DZ (1) DZ3048A1 (de)
EA (1) EA200101130A1 (de)
EE (1) EE200100631A (de)
ES (1) ES2220426T3 (de)
GT (1) GT200000078A (de)
HK (1) HK1046282A1 (de)
HN (1) HN2000000075A (de)
HR (1) HRP20010856A2 (de)
HU (1) HUP0201433A2 (de)
IL (1) IL145947A0 (de)
IS (1) IS6135A (de)
MA (1) MA26736A1 (de)
MX (1) MXPA01012125A (de)
NO (1) NO20015756L (de)
OA (1) OA11950A (de)
PA (1) PA8495701A1 (de)
PE (1) PE20010169A1 (de)
PL (1) PL353483A1 (de)
PT (1) PT1180102E (de)
SK (1) SK16792001A3 (de)
SV (1) SV2002000082A (de)
TN (1) TNSN00113A1 (de)
TR (1) TR200103391T2 (de)
WO (1) WO2000073298A1 (de)
ZA (1) ZA200109691B (de)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GT199800127A (es) * 1997-08-29 2000-02-01 Combinaciones terapeuticas.
US6737430B2 (en) 2000-11-09 2004-05-18 Pfizer, Inc. Mutual prodrug of amlodipine and atorvastatin
GB0027410D0 (en) * 2000-11-09 2000-12-27 Pfizer Ltd Mutual prodrug of amlodipine and atorvastatin
US7232924B2 (en) 2001-06-11 2007-06-19 Xenoport, Inc. Methods for synthesis of acyloxyalkyl derivatives of GABA analogs
US6818787B2 (en) 2001-06-11 2004-11-16 Xenoport, Inc. Prodrugs of GABA analogs, compositions and uses thereof
US8048917B2 (en) 2005-04-06 2011-11-01 Xenoport, Inc. Prodrugs of GABA analogs, compositions and uses thereof
AU2002310409C1 (en) 2001-06-11 2008-04-17 Xenoport, Inc. Orally administered dosage forms of GABA analog prodrugs having reduced toxicity
US7186855B2 (en) 2001-06-11 2007-03-06 Xenoport, Inc. Prodrugs of GABA analogs, compositions and uses thereof
DE10140421A1 (de) * 2001-08-17 2003-03-06 Bayer Ag Neue Kombination
US7670612B2 (en) 2002-04-10 2010-03-02 Innercap Technologies, Inc. Multi-phase, multi-compartment capsular delivery apparatus and methods for using same
US7071210B2 (en) * 2002-07-02 2006-07-04 Pfizer Inc. CETP inhibitors in combination with antihypertensive agents and uses thereof
US20040053842A1 (en) * 2002-07-02 2004-03-18 Pfizer Inc. Methods of treatment with CETP inhibitors and antihypertensive agents
EP1811986B1 (de) 2004-11-04 2014-03-26 XenoPort, Inc. Orale darreichungsformen von gabapentin-prodrug mit verzögerter freisetzung
EP1909848A2 (de) * 2005-08-01 2008-04-16 PSivida Inc. Hmgcoa-reduktase-inhibitor-angiotensin zur umwandlung von enzym-inhibitor-verbindungen
AR057882A1 (es) 2005-11-09 2007-12-26 Novartis Ag Compuestos de accion doble de bloqueadores del receptor de angiotensina e inhibidores de endopeptidasa neutra
US8354116B2 (en) * 2007-06-18 2013-01-15 Biochemics, Inc. Bifunctional synthetic molecules
US8371336B2 (en) 2007-10-10 2013-02-12 Eagle Industry Co., Ltd. Accumulator

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK161312C (da) 1982-03-11 1991-12-09 Pfizer Analogifremgangsmaade til fremstilling af 2-aminoalkoxymethyl-4-phenyl-6-methyl-1,4-dihydropyridin-3,5-dicarboxylsyreestere eller syreadditionssalte deraf samt phthalimidoderivater til anvendelse som udgangsmateriale ved fremgangsmaaden
GB8608335D0 (en) 1986-04-04 1986-05-08 Pfizer Ltd Pharmaceutically acceptable salts
US4681893A (en) 1986-05-30 1987-07-21 Warner-Lambert Company Trans-6-[2-(3- or 4-carboxamido-substituted pyrrol-1-yl)alkyl]-4-hydroxypyran-2-one inhibitors of cholesterol synthesis
FI94339C (fi) 1989-07-21 1995-08-25 Warner Lambert Co Menetelmä farmaseuttisesti käyttökelpoisen /R-(R*,R*)/-2-(4-fluorifenyyli)- , -dihydroksi-5-(1-metyylietyyli)-3-fenyyli-4-/(fenyyliamino)karbonyyli/-1H-pyrroli-1-heptaanihapon ja sen farmaseuttisesti hyväksyttävien suolojen valmistamiseksi
US5155120A (en) 1991-01-14 1992-10-13 Pfizer Inc Method for treating congestive heart failure
GT199800127A (es) * 1997-08-29 2000-02-01 Combinaciones terapeuticas.

Also Published As

Publication number Publication date
ATE268764T1 (de) 2004-06-15
CA2375372A1 (en) 2000-12-07
DZ3048A1 (fr) 2004-03-27
MXPA01012125A (es) 2002-06-04
ZA200109691B (en) 2002-11-26
DE60011424D1 (de) 2004-07-15
BR0011006A (pt) 2002-02-19
IS6135A (is) 2001-10-30
HN2000000075A (es) 2001-02-02
CO5170457A1 (es) 2002-06-27
AR022344A1 (es) 2002-09-04
CA2375372C (en) 2007-01-09
PL353483A1 (en) 2003-11-17
EP1180102B1 (de) 2004-06-09
EP1180102B9 (de) 2005-03-02
WO2000073298A1 (en) 2000-12-07
MA26736A1 (fr) 2004-12-20
EA200101130A1 (ru) 2002-04-25
PA8495701A1 (es) 2001-12-14
ES2220426T3 (es) 2004-12-16
TR200103391T2 (tr) 2002-04-22
CN1352640A (zh) 2002-06-05
SK16792001A3 (sk) 2003-03-04
JP2003500487A (ja) 2003-01-07
NO20015756L (no) 2002-01-24
DK1180102T3 (da) 2004-09-06
EE200100631A (et) 2003-02-17
PT1180102E (pt) 2004-08-31
HRP20010856A2 (en) 2002-12-31
KR20020012247A (ko) 2002-02-15
PE20010169A1 (es) 2001-02-10
HUP0201433A2 (en) 2002-08-28
BG106149A (bg) 2002-05-31
DE60011424T2 (de) 2005-08-25
HK1046282A1 (zh) 2003-01-03
AP2001002345A0 (en) 2001-12-31
AU3313900A (en) 2000-12-18
EP1180102A1 (de) 2002-02-20
SV2002000082A (es) 2002-02-05
CZ20014229A3 (cs) 2003-01-15
OA11950A (en) 2006-04-13
TNSN00113A1 (fr) 2005-11-10
US6486182B1 (en) 2002-11-26
NO20015756D0 (no) 2001-11-26
GT200000078A (es) 2001-11-16

Similar Documents

Publication Publication Date Title
EG22599A (en) Trifluormethylpyrrolecarboxamides and trifluoromethylpyrrolethioamides as fungicides
EP1146790A4 (de) Verbindungen und verfahren
EP1223932A4 (de) Verbindungen und verfahren
GB0004544D0 (en) Polymers their preparation and uses
HRP20060251B1 (hr) Supstituirani oksazolidinoni i njihova uporaba
IL145837A0 (en) Mutual salt of amlodipine and atorvastatin
EP1194147A4 (de) Arylthiazolidindion- und aryloxazolidinderivate
HUP0301076A3 (en) Linezolid-crystal form ii and preparation thereof
PL353483A1 (en) Mutual prodrugs of amlodipine and atorvastatin
IL143423A0 (en) Insecticidal compositions and insecticidal methods
HUP0203896A3 (en) Substituted 8-arylquinoline phosphodiesterase-4-inhibitors and use thereof
GB0023323D0 (en) Arylhydantoin derivatives and uses thereof
EP1229913A4 (de) Substituierte 1-benzazepine und dessen derivate
GB9925634D0 (en) Modification of plants
PL351408A1 (en) Synergistic effects of amlodipine and atorvastatin
SI1180102T1 (en) Mutual prodrugs of amlodipine and atorvastatin
GB0027410D0 (en) Mutual prodrug of amlodipine and atorvastatin
HU0101919D0 (en) Environment-frienly deterrents and preparation thereof
HU1714U (en) Fence consisting of identical structural elements
HU9900075V0 (en) Sepulchre consists of elements
GB9916675D0 (en) Enigma-sip and enigma-cell
GB9912409D0 (en) Compounds and compositions
GB9909843D0 (en) Compounds and their use
GB9909549D0 (en) Racetrack
AU140300S (en) Toy armoire